Inflammation and premature aging in advanced chronic kidney disease

American Journal of Physiology - Renal Physiology

Volumn 313, Issue 4, 2017, Pages F938-F950

  Kooman, Jeroen P ^a   Dekker, Marijke J ^a   Usvyat, Len A ^b   Kotanko, Peter ^c,d   van der Sande, Frank M ^b   Schalkwijk, Casper G ^a   Shiels, Paul G ^e   Stenvinkel, Peter ^f  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^b FRESENIUS MEDICAL CARE NORTH AMERICA   (United States)

^c RENAL RESEARCH INSTITUTE   (United States)

^d MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF GLASGOW   (United Kingdom)

^f KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Aging; End stage renal disease; Inflammation

Indexed keywords

KLOTHO PROTEIN; PHOSPHATE;

CHRONIC KIDNEY FAILURE; DISORDERS OF MITOCHONDRIAL FUNCTIONS; END STAGE RENAL DISEASE; HOMEOSTASIS; INFLAMMATION; NONHUMAN; NUTRIENT; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PHENOTYPE; PREMATURE AGING; PRIORITY JOURNAL; REVIEW; SENESCENCE; SIGNAL TRANSDUCTION; TELOMERE SHORTENING; AGING; ANIMAL; COMPLICATION; HUMAN; IMMUNOLOGY; UREMIA;

AGING; AGING, PREMATURE; ANIMALS; HUMANS; RENAL INSUFFICIENCY, CHRONIC; UREMIA;

EID: 85029492940     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.00256.2017     Document Type: Review

References (177)

1. Allison BJ, Kaandorp JJ, Kane AD, Camm EJ, Lusby C, Cross CM, Nevin-Dolan R, Thakor AS, Derks JB, Tarry-Adkins JL, Ozanne SE, Giussani DA. Divergence of mechanistic pathways mediating cardiovascular aging and developmental programming of cardiovascular disease. FASEB J 30: 1968-1975, 2016. doi:10.1096/fj.201500057.
2. Axelsson J, Heimbürger O, Lindholm B, Stenvinkel P. Adipose tissue and its relation to inflammation: the role of adipokines. J Ren Nutr 15: 131-136, 2005. doi:10.1053/j.jrn.2004.09.034.
3. Azevedo ML, Bonan NB, Dias G, Brehm F, Steiner TM, Souza WM, Stinghen AE, Barreto FC, Elifio-Esposito S, Pecoits-Filho R, Moreno-Amaral AN. p-Cresyl sulfate affects the oxidative burst, phago-cytosis process, and antigen presentation of monocyte-derived macrophages. Toxicol Lett 263: 1-5, 2016. doi:10.1016/j.toxlet.2016.10.006.
4. Baar MP, Brandt RM, Putavet DA, Klein JD, Derks KW, Bourgeois BR, Stryeck S, Rijksen Y, van Willigenburg H, Feijtel DA, van der Pluijm I, Essers J, van Cappellen WA, van IJcken WF, Houtsmuller AB, Pothof J, de Bruin RW, Madl T, Hoeijmakers JH, Campisi J, de Keizer PL. Targeted apoptosis of senescent cells restores tissue homeostasis in response to chemotoxicity and aging. Cell 169: 132-147.e16, 2017. doi:10.1016/j.cell.2017.02.031.
5. Baker DJ, Childs BG, Durik M, Wijers ME, Sieben CJ, Zhong J, Saltness RA, Jeganathan KB, Verzosa GC, Pezeshki A, Khazaie K, Miller JD, van Deursen JM. Naturally occurring p16(Ink4a)-positive cells shorten healthy lifespan. Nature 530: 184-189, 2016. doi:10.1038/nature16932.
6. Barnes PJ. Senescence in COPD and its comorbidities. Annu Rev Physiol 79: 517-539, 2017. doi:10.1146/annurev-physiol-022516-034314.
7. Bessueille L, Magne D. Inflammation: a culprit for vascular calcification in atherosclerosis and diabetes. Cell Mol Life Sci 72: 2475-2489, 2015. doi:10.1007/s00018-015-1876-4.
8. Betjes MG, Langerak AW, van der Spek A, de Wit EA, Litjens NH. Premature aging of circulating T cells in patients with end-stage renal disease. Kidney Int 80: 208-217, 2011. doi:10.1038/ki.2011.110.
9. Betjes MG, Meijers RW, Litjens NH. Loss of renal function causes premature aging of the immune system. Blood Purif 36: 173-178, 2013. doi:10.1159/000356084.
10. Binger KJ, Gebhardt M, Heinig M, Rintisch C, Schroeder A, Neuhofer W, Hilgers K, Manzel A, Schwartz C, Kleinewietfeld M, Voelkl J, Schatz V, Linker RA, Lang F, Voehringer D, Wright MD, Hubner N, Dechend R, Jantsch J, Titze J, Müller DN. High salt reduces the activation of IL-4-and IL-13-stimulated macrophages. J Clin Invest 125: 4223-4238, 2015. doi:10.1172/JCI80919.
11. Bro S, Flyvbjerg A, Binder CJ, Bang CA, Denner L, Olgaard K, Nielsen LB. A neutralizing antibody against receptor for advanced glycation end products (RAGE) reduces atherosclerosis in uremic mice. Atherosclerosis 201: 274-280, 2008. doi:10.1016/j.atherosclerosis.2008. 01.015.
12. Bruchfeld A, Qureshi AR, Lindholm B, Barany P, Yang L, Stenvinkel P, Tracey KJ. High mobility group box protein-1 correlates with renal function in chronic kidney disease (CKD). Mol Med 14: 109-115, 2008. doi:10.2119/2007-00107.Bruchfeld.
13. Buendía P, Carracedo J, Soriano S, Madueño JA, Ortiz A, Martín-Malo A, Aljama P, Ramírez R. Klotho prevents NF-κB translocation and protects endothelial cell from senescence induced by uremia. J Gerontol A Biol Sci Med Sci 70: 1198-1209, 2015. doi:10.1093/gerona/glu170.
14. Caballo C, Palomo M, Cases A, Galán AM, Molina P, Vera M, Bosch X, Escolar G, Diaz-Ricart M. NF-κB in the development of endothelial activation and damage in uremia: an in vitro approach. PLoS One 7: e43374, 2012. doi:10.1371/journal.pone.0043374.
15. Caglar K, Yilmaz MI, Saglam M, Cakir E, Acikel C, Eyileten T, Yenicesu M, Oguz Y, Vural A, Carrero JJ, Axelsson J, Lindholm B, Stenvinkel P. Short-term treatment with sevelamer increases serum fetuin-a concentration and improves endothelial dysfunction in chronic kidney disease stage 4 patients. Clin J Am Soc Nephrol 3: 61-68, 2008. doi:10.2215/CJN.02810707.
16. Carracedo J, Buendía P, Merino A, Soriano S, Esquivias E, Martín-Malo A, Aljama P, Ramírez R. Cellular senescence determines endothelial cell damage induced by uremia. Exp Gerontol 48: 766-773, 2013. doi:10.1016/j.exger.2013.04.004.
17. Carrero JJ, Stenvinkel P. Inflammation in end-stage renal disease— what have we learned in 10 years? Semin Dial 23: 498-509, 2010. doi:10.1111/j.1525-139X.2010.00784.x.
18. Carrero JJ, Stenvinkel P. Persistent inflammation as a catalyst for other risk factors in chronic kidney disease: a hypothesis proposal. Clin J Am Soc Nephrol 4, Suppl 1: S49-S55, 2009. doi:10.2215/CJN.02720409.
19. Carrero JJ, Stenvinkel P, Fellström B, Qureshi AR, Lamb K, Heimbürger O, Bárány P, Radhakrishnan K, Lindholm B, Soveri I, Nordfors L, Shiels PG. Telomere attrition is associated with inflammation, low fetuin-A levels and high mortality in prevalent haemodialysis patients. J Intern Med 263: 302-312, 2008. doi:10.1111/j.1365-2796.2007.01890.x.
20. Castellino P, Bia M, DeFronzo RA. Metabolic response to exercise in dialysis patients. Kidney Int 32: 877-883, 1987. doi:10.1038/ki.1987. 289.
21. Chen WT, Hung KC, Wen MS, Hsu PY, Chen TH, Wang HD, Fang JT, Shie SS, Wang CY. Impaired leukocytes autophagy in chronic kidney disease patients. Cardiorenal Med 3: 254-264, 2013. doi:10.1159/000356212.
22. Chen Z, Qureshi AR, Ripsweden J, Wennberg L, Heimburger O, Lindholm B, Barany P, Haarhaus M, Brismar TB, Stenvinkel P. Vertebral bone density associates with coronary artery calcification and is an independent predictor of poor outcome in end-stage renal disease patients. Bone 92: 50-57, 2016. doi:10.1016/j.bone.2016.08.007.
23. Childs BG, Durik M, Baker DJ, van Deursen JM. Cellular senescence in aging and age-related disease: from mechanisms to therapy. Nat Med 21: 1424-1435, 2015. doi:10.1038/nm.4000.
24. Costello-White R, Ryff CD, Coe CL. Aging and low-grade inflammation reduce renal function in middle-aged and older adults in Japan and the USA. Age (Dordr) 37: 75, 2015. doi:10.1007/s11357-015-9808-7.
25. Dai XY, Zhao MM, Cai Y, Guan QC, Zhao Y, Guan Y, Kong W, Zhu WG, Xu MJ, Wang X. Phosphate-induced autophagy counteracts vascular calcification by reducing matrix vesicle release. Kidney Int 83: 1042-1051, 2013. doi:10.1038/ki.2012.482.
26. Danyan C, Xiaolong H, Song L, Hua G, Weixue T, Ke L. The effects of rhBMP-2 and Treg/Th17 functional disequilibrium in uremic patients with cardiovascular complication after maintenance hemodialysis. Int J Artif Organs 36: 464-472, 2013. doi:10.5301/ijao.5000217.
27. de Zeeuw D, Akizawa T, Audhya P, Bakris GL, Chin M, Christ-Schmidt H, Goldsberry A, Houser M, Krauth M, Lambers Heer-spink HJ, McMurray JJ, Meyer CJ, Parving HH, Remuzzi G, Toto RD, Vaziri ND, Wanner C, Wittes J, Wrolstad D, Chertow GM; BEACON Trial Investigators. Bardoxolone methyl in type 2 diabetes and stage 4 chronic kidney disease. N Engl J Med 369: 2492-2503, 2013. doi:10.1056/NEJMoa1306033.
28. Deban L, Bottazzi B, Garlanda C, de la Torre YM, Mantovani A. Pentraxins: multifunctional proteins at the interface of innate immunity and inflammation. Biofactors 35: 138-145, 2009. doi:10.1002/biof.21.
29. Dekker MJ, Marcelli D, Canaud B, Konings CJ, Leunissen KM, Levin NW, Carioni P, Maheshwari V, Raimann JG, van der Sande FM, Usvyat LA, Kotanko P, Kooman JP. Unraveling the relationship between mortality, hyponatremia, inflammation and malnutrition in hemodialysis patients: results from the international MONDO initiative. Eur J Clin Nutr 70: 779-784, 2016. doi:10.1038/ejcn.2016.49.
30. Demirci MS, Demirci C, Ozdogan O, Kircelli F, Akcicek F, Basci A, Ok E, Ozkahya M. Relations between malnutrition-inflammation-atherosclerosis and volume status. The usefulness of bioimpedance analysis in peritoneal dialysis patients. Nephrol Dial Transplant 26: 1708-1716, 2011. doi:10.1093/ndt/gfq588.
31. Dickhout JG, Carlisle RE, Austin RC. Interrelationship between cardiac hypertrophy, heart failure, and chronic kidney disease: endoplasmic reticulum stress as a mediator of pathogenesis. Circ Res 108: 629-642, 2011. doi:10.1161/CIRCRESAHA.110.226803.
32. Drew DA, Bhadelia R, Tighiouart H, Novak V, Scott TM, Lou KV, Shaffi K, Weiner DE, Sarnak MJ. Anatomic brain disease in hemodialysis patients: a cross-sectional study. Am J Kidney Dis 61: 271-278, 2013. doi:10.1053/j.ajkd.2012.08.035.
33. Dungey M, Hull KL, Smith AC, Burton JO, Bishop NC. Inflammatory factors and exercise in chronic kidney disease. Int J Endocrinol 2013: 569831, 2013. doi:10.1155/2013/569831.
34. Ekdahl KN, Soveri I, Hilborn J, Fellström B, Nilsson B. Cardiovascular disease in haemodialysis: role of the intravascular innate immune system. Nat Rev Nephrol 13: 285-296, 2017. doi:10.1038/nrneph.2017.17.
35. Eltzschig HK, Carmeliet P. Hypoxia and inflammation. N Engl J Med 364: 656-665, 2011. doi:10.1056/NEJMra0910283.
36. Erdó F, Denes L, de Lange E. Age-associated physiological and pathological changes at the blood-brain barrier: A review. J Cereb Blood Flow Metab 37: 4-24, 2017. doi:10.1177/0271678X16679420.
37. Fan S, Davenport A. Does increased glucose exposure lead to increased body fat and reduced lean body mass in anuric peritoneal dialysis patients? Eur J Clin Nutr 68: 1253-1254, 2014. doi:10.1038/ejcn.2014. 119.
38. Franceschi C, Garagnani P, Vitale G, Capri M, Salvioli S. Inflammaging and ‘Garb-aging’. Trends Endocrinol Metab 28: 199-212, 2017. doi:10.1016/j.tem.2016.09.005.
39. Frost RA, Lang CH. mTor signaling in skeletal muscle during sepsis and inflammation: where does it all go wrong? Physiology (Bethesda) 26: 83-96, 2011. doi:10.1152/physiol.00044.2010.
40. Galle J, Seibold S, Wanner C. Inflammation in uremic patients: what is the link? Kidney Blood Press Res 26: 65-75, 2003. doi:10.1159/000070986.
41. Gardner SE, Humphry M, Bennett MR, Clarke MC. Senescent vascular smooth muscle cells drive inflammation through an interleukin-1α-dependent senescence-associated secretory phenotype. Arterioscler Thromb Vasc Biol 35: 1963-1974, 2015. doi:10.1161/ATVBAHA.115. 305896.
42. Granata S, Masola V, Zoratti E, Scupoli MT, Baruzzi A, Messa M, Sallustio F, Gesualdo L, Lupo A, Zaza G. NLRP3 inflammasome activation in dialyzed chronic kidney disease patients. PLoS One 10: e0122272, 2015. doi:10.1371/journal.pone.0122272.
43. Hartmann G, Tschöp M, Fischer R, Bidlingmaier C, Riepl R, Tschöp K, Hautmann H, Endres S, Toepfer M. High altitude increases circulating interleukin-6, interleukin-1 receptor antagonist and C-reactive protein. Cytokine 12: 246-252, 2000. doi:10.1006/cyto.1999.0533.
44. Hellberg M, Hoglund P, Svensson P, Abdulahi H, and Clyne N. Decline in measured glomerular filtration rate is associated with a decrease in endurance, strength, balance and fine motor skills. Nephrology (Carlton) 22: 513-519, 2017. doi:10.1111/nep.12810.
45. Hermans MM, Brandenburg V, Ketteler M, Kooman JP, van der Sande FM, Boeschoten EW, Leunissen KM, Krediet RT, Dekker FW; Netherlands cooperative study on the adequacy of Dialysis (NECOSAD). Association of serum fetuin-A levels with mortality in dialysis patients. Kidney Int 72: 202-207, 2007. doi:10.1038/sj.ki. 5002178.
46. Hernandez AL, Kitz A, Wu C, Lowther DE, Rodriguez DM, Vudattu N, Deng S, Herold KC, Kuchroo VK, Kleinewietfeld M, Hafler DA. Sodium chloride inhibits the suppressive function of FOXP3+ regulatory T cells. J Clin Invest 125: 4212-4222, 2015. doi:10.1172/JCI81151.
47. Himmelfarb J, Stenvinkel P, Ikizler TA, Hakim RM. The elephant in uremia: oxidant stress as a unifying concept of cardiovascular disease in uremia. Kidney Int 62: 1524-1538, 2002. doi:10.1046/j.1523-1755.2002. 00600.x.
48. Hizawa N. Clinical approaches towards asthma and chronic obstructive pulmonary disease based on the heterogeneity of disease pathogenesis. Clin Exp Allergy 46: 678-687, 2016. doi:10.1111/cea.12731.
49. Holmén C, Elsheikh E, Stenvinkel P, Qureshi AR, Pettersson E, Jalkanen S, Sumitran-Holgersson S. Circulating inflammatory endothelial cells contribute to endothelial progenitor cell dysfunction in patients with vasculitis and kidney involvement. J Am Soc Nephrol 16: 3110-3120, 2005. doi:10.1681/ASN.2005040347.
50. Honda H, Qureshi AR, Axelsson J, Heimburger O, Suliman ME, Barany P, Stenvinkel P, Lindholm B. Obese sarcopenia in patients with end-stage renal disease is associated with inflammation and increased mortality. Am J Clin Nutr 86: 633-638, 2007.
51. Izquierdo MC, Perez-Gomez MV, Sanchez-Niño MD, Sanz AB, Ruiz-Andres O, Poveda J, Moreno JA, Egido J, Ortiz A. Klotho, phosphate and inflammation/ageing in chronic kidney disease. Nephrol Dial Transplant 27, Suppl 4: iv6-iv10, 2012. doi:10.1093/ndt/gfs426.
52. Jacobs LH, van de Kerkhof JJ, Mingels AM, Passos VL, Kleijnen VW, Mazairac AH, van der Sande FM, Wodzig WK, Konings CJ, Leunissen KM, van Dieijen-Visser MP, Kooman JP. Inflammation, overhydration and cardiac biomarkers in haemodialysis patients: a longitudinal study. Nephrol Dial Transplant 25: 243-248, 2010. doi:10.1093/ndt/gfp417.
53. + storage strengthens the antimicrobial barrier function of the skin and boosts macrophage-driven host defense. Cell Metab 21: 493-501, 2015. doi:10.1016/j.cmet. 2015.02.003.
54. Johansen KL, Chertow GM, Jin C, Kutner NG. Significance of frailty among dialysis patients. J Am Soc Nephrol 18: 2960-2967, 2007. doi:10.1681/ASN.2007020221.
55. John B, Tan BK, Dainty S, Spanel P, Smith D, Davies SJ. Plasma volume, albumin, and fluid status in peritoneal dialysis patients. Clin J Am Soc Nephrol 5: 1463-1470, 2010. doi:10.2215/CJN.09411209.
56. Jurk D, Wilson C, Passos JF, Oakley F, Correia-Melo C, Greaves L, Saretzki G, Fox C, Lawless C, Anderson R, Hewitt G, Pender SL, Fullard N, Nelson G, Mann J, van de Sluis B, Mann DA, von Zglinicki T. Chronic inflammation induces telomere dysfunction and accelerates ageing in mice. Nat Commun 2: 4172, 2014. doi:10.1038/ncomms5172.
57. Kanda N, Matsui K, Kawai T, Edamatsu H, Tanuma Y, Suzuki O, Takahashi T, Kamakura S. Implantation of octacalcium phosphate collagen composites (OCP/Col) after extraction of canine deciduous teeth achieved undisturbed permanent tooth eruption. Arch Oral Biol 72: 179-186, 2016. doi:10.1016/j.archoralbio.2016.08.027.
58. Kato S, Chmielewski M, Honda H, Pecoits-Filho R, Matsuo S, Yuzawa Y, Tranaeus A, Stenvinkel P, Lindholm B. Aspects of immune dysfunction in end-stage renal disease. Clin J Am Soc Nephrol 3: 1526-1533, 2008. doi:10.2215/CJN.00950208.
59. Kauppinen A, Suuronen T, Ojala J, Kaarniranta K, Salminen A. Antagonistic crosstalk between NF-κB and SIRT1 in the regulation of inflammation and metabolic disorders. Cell Signal 25: 1939-1948, 2013. doi:10.1016/j.cellsig.2013.06.007.
60. Kaysen GA. Inflammation and oxidative stress in end-stage renal disease. Adv Nephrol Necker Hosp 30: 201-214, 2000.
61. Keyzer CA, de Borst MH, van den Berg E, Jahnen-Dechent W, Arampatzis S, Farese S, Bergmann IP, Floege J, Navis G, Bakker SJ, van Goor H, Eisenberger U, Pasch A. Calcification propensity and survival among renal transplant recipients. J Am Soc Nephrol 27: 239-248, 2016. doi:10.1681/ASN.2014070670.
62. Kim HJ, Vaziri ND. Contribution of impaired Nrf2-Keap1 pathway to oxidative stress and inflammation in chronic renal failure. Am J Physiol Renal Physiol 298: F662-F671, 2010. doi:10.1152/ajprenal.00421.2009.
63. Kirk JE. The glyoxalase I activity of arterial tissue in individuals of various ages. J Gerontol 15: 139-141, 1960. doi:10.1093/geronj/15.2. 139.
64. Kleinewietfeld M, Manzel A, Titze J, Kvakan H, Yosef N, Linker RA, Muller DN, Hafler DA. Sodium chloride drives autoimmune disease by the induction of pathogenic TH17 cells. Nature 496: 518-522, 2013. doi:10.1038/nature11868.
65. Klokker M, Kharazmi A, Galbo H, Bygbjerg I, Pedersen BK. Influence of in vivo hypobaric hypoxia on function of lymphocytes, neutro-cytes, natural killer cells, and cytokines. J Appl Physiol (1985) 74: 1100-1106, 1993.
66. Konings CJ, Kooman JP, Schonck M, Struijk DG, Gladziwa U, Hoorntje SJ, van der Wall Bake AW, van der Sande FM, Leunissen KM. Fluid status in CAPD patients is related to peritoneal transport and residual renal function: evidence from a longitudinal study. Nephrol Dial Transplant 18: 797-803, 2003. doi:10.1093/ndt/gfg147.
67. Kooman JP, Broers NJ, Usvyat L, Thijssen S, van der Sande FM, Cornelis T, Levin NW, Leunissen KM, Kotanko P. Out of control: accelerated aging in uremia. Nephrol Dial Transplant 28: 48-54, 2013. doi:10.1093/ndt/gfs451.
68. Kooman JP, Kotanko P, Schols AM, Shiels PG, Stenvinkel P. Chronic kidney disease and premature ageing. Nat Rev Nephrol 10: 732-742, 2014. doi:10.1038/nrneph.2014.185.
69. Kooman JP, Usvyat L, van der Sande FM, Thijssen S, Levin N, Leunissen KM, Kotanko P. ‘Time and time again’: oscillatory and longitudinal time patterns in dialysis patients. Kidney Blood Press Res 35: 534-548, 2012. doi:10.1159/000340022.
70. Kramann R, Goettsch C, Wongboonsin J, Iwata H, Schneider RK, Kuppe C, Kaesler N, Chang-Panesso M, Machado FG, Gratwohl S, Madhurima K, Hutcheson JD, Jain S, Aikawa E, Humphreys BD. Adventitial MSC-like cells are progenitors of vascular smooth muscle cells and drive vascular calcification in chronic kidney disease. Cell Stem Cell 19: 628-642, 2016. doi:10.1016/j.stem.2016.08.001.
71. Kshirsagar AV, Craig RG, Beck JD, Moss K, Offenbacher S, Kotanko P, Yoshino M, Levin NW, Yip JK, Almas K, Lupovici E, Falk RJ. Severe periodontitis is associated with low serum albumin among patients on maintenance hemodialysis therapy. Clin J Am Soc Nephrol 2: 239-244, 2007. doi:10.2215/CJN.02420706.
72. Kshirsagar AV, Craig RG, Moss KL, Beck JD, Offenbacher S, Kotanko P, Klemmer PJ, Yoshino M, Levin NW, Yip JK, Almas K, Lupovici EM, Usvyat LA, Falk RJ. Periodontal disease adversely affects the survival of patients with end-stage renal disease. Kidney Int 75: 746-751, 2009. doi:10.1038/ki.2008.660.
73. Kuro-o M. Klotho, phosphate and FGF-23 in ageing and disturbed mineral metabolism. Nat Rev Nephrol 9: 650-660, 2013. doi:10.1038/nrneph.2013.111.
74. Lau WL, Liu SM, Pahlevan S, Yuan J, Khazaeli M, Ni Z, Chan JY, Vaziri ND. Role of Nrf2 dysfunction in uremia-associated intestinal inflammation and epithelial barrier disruption. Dig Dis Sci 60: 1215-1222, 2015. doi:10.1007/s10620-014-3428-4.
75. Lee CT, Tsai YC, Ng HY, Su Y, Lee WC, Lee LC, Chiou TT, Liao SC, Hsu KT. Association between C-reactive protein and biomarkers of bone and mineral metabolism in chronic hemodialysis patients: a cross-sectional study. J Ren Nutr 19: 220-227, 2009. doi:10.1053/j.jrn.2008. 11.004.
76. Leemans JC, Kors L, Anders HJ, Florquin S. Pattern recognition receptors and the inflammasome in kidney disease. Nat Rev Nephrol 10: 398-414, 2014. doi:10.1038/nrneph.2014.91.
77. Li G, Tang D, Lotze MT. Ménage à Trois in stress: DAMPs, redox and autophagy. Semin Cancer Biol 23: 380-390, 2013. doi:10.1016/j.semcancer.2013.08.002.
78. Libetta C, Sepe V, Esposito P, Galli F, Dal Canton A. Oxidative stress and inflammation: Implications in uremia and hemodialysis. Clin Biochem 44: 1189-1198, 2011. doi:10.1016/j.clinbiochem.2011.06.988.
79. Liu J, Huang K, Cai GY, Chen XM, Yang JR, Lin LR, Yang J, Huo BG, Zhan J, He YN. Receptor for advanced glycation end-products promotes premature senescence of proximal tubular epithelial cells via activation of endoplasmic reticulum stress-dependent p21 signaling. Cell Signal 26: 110-121, 2014. doi:10.1016/j.cellsig.2013.10.002.
80. López-Otín C, Blasco MA, Partridge L, Serrano M, Kroemer G. The hallmarks of aging. Cell 153: 1194-1217, 2013. doi:10.1016/j.cell.2013. 05.039.
81. Machowska A, Carrero JJ, Lindholm B, Stenvinkel P. Therapeutics targeting persistent inflammation in chronic kidney disease. Transl Res 167: 204-213, 2016. doi:10.1016/j.trsl.2015.06.012.
82. Maessen DE, Stehouwer CD, Schalkwijk CG. The role of methylg-lyoxal and the glyoxalase system in diabetes and other age-related diseases. Clin Sci (Lond) 128: 839-861, 2015. doi:10.1042/CS20140683.
83. Mafra D, Fouque D. Gut microbiota and inflammation in chronic kidney disease patients. Clin Kidney J 8: 332-334, 2015. doi:10.1093/ckj/sfv026.
84. Manfredini F, Mallamaci F, D’Arrigo G, Baggetta R, Bolignano D, Torino C, Lamberti N, Bertoli S, Ciurlino D, Rocca-Rey L, Barillà A, Battaglia Y, Rapanà RM, Zuccalà A, Bonanno G, Fatuzzo P, Rap-isarda F, Rastelli S, Fabrizi F, Messa P, De Paola L, Lombardi L, Cupisti A, Fuiano G, Lucisano G, Summaria C, Felisatti M, Pozzato E, Malagoni AM, Castellino P, Aucella F, Abd ElHafeez S, Provenzano PF, Tripepi G, Catizone L, Zoccali C. Exercise in patients on dialysis: a multicenter, randomized clinical trial. J Am Soc Nephrol 28: 1259-1268, 2017. doi:10.1681/ASN.2016030378.
85. Marcelli D, Brand K, Ponce P, Milkowski A, Marelli C, Ok E, Merello Godino JI, Gurevich K, Jirka T, Rosenberger J, Di Bene-detto A, Ladanyi E, Grassmann A, Scatizzi L, Bayh I, Kooman J, Canaud B. Longitudinal changes in body composition in patients after initiation of hemodialysis therapy: results from an international cohort. J Ren Nutr 26: 72-80, 2016. doi:10.1053/j.jrn.2015.10.001.
86. Marcelli D, Usvyat LA, Kotanko P, Bayh I, Canaud B, Etter M, Gatti E, Grassmann A, Wang Y, Marelli C, Scatizzi L, Stopper A, van der Sande FM, Kooman J; MONitoring Dialysis Outcomes (MONDO) Consortium. Body composition and survival in dialysis patients: results from an international cohort study. Clin J Am Soc Nephrol 10: 1192-1200, 2015. doi:10.2215/CJN.08550814.
87. Margolick JB, Ferrucci L. Accelerating aging research: how can we measure the rate of biologic aging? Exp Gerontol 64: 78-80, 2015. doi:10.1016/j.exger.2015.02.009.
88. Martens RJ, Kooman JP, Stehouwer CD, Dagnelie PC, van der Kallen CJ, Koster A, Kroon AA, Leunissen KM, Nijpels G, van der Sande FM, Schaper NC, Sep SJ, van Boxtel MP, Schram MT, Henry RM. Estimated GFR, albuminuria, and cognitive performance: the Maastricht Study. Am J Kidney Dis 69: 179-191, 2017. doi:10.1053/j.ajkd. 2016.04.017.
89. Martin-Rodriguez S, Caballo C, Gutierrez G, Vera M, Cruzado JM, Cases A, Escolar G, Diaz-Ricart M. TLR4 and NALP3 inflammasome in the development of endothelial dysfunction in uraemia. Eur J Clin Invest 45: 160-169, 2015. doi:10.1111/eci.12392.
90. McCullough PA, Ali S. Cardiac and renal function in patients with type 2 diabetes who have chronic kidney disease: potential effects of bardoxolone methyl. Drug Des Devel Ther 6: 141-149, 2012. doi:10.2147/DDDT.S26714.
91. McGuinness D, Leierer J, Shapter O, Mohammed S, Gingell-Little-john M, Kingsmore DB, Little AM, Kerschbaum J, Schneeberger S, Maglione M, Nadalin S, Wagner S, Königsrainer A, Aitken E, Whalen H, Clancy M, McConnachie A, Koppelstaetter C, Stevenson KS, Shiels PG. Identification of molecular markers of delayed graft function based on the regulation of biological ageing. PLoS One 11: e0146378, 2016. [Erratum. PLoS One 11: e0151506, 2016.] doi:10.1371/journal.pone.0146378.
92. McGuinness D, McGlynn LM, Johnson PC, MacIntyre A, Batty GD, Burns H, Cavanagh J, Deans KA, Ford I, McConnachie A, McGinty A, McLean JS, Millar K, Packard CJ, Sattar NA, Tannahill C, Velupillai YN, Shiels PG. Socio-economic status is associated with epigenetic differences in the pSoBid cohort. Int J Epidemiol 41: 151-160, 2012. doi:10.1093/ije/dyr215.
93. McIntyre CW, Harrison LE, Eldehni MT, Jefferies HJ, Szeto CC, John SG, Sigrist MK, Burton JO, Hothi D, Korsheed S, Owen PJ, Lai KB, Li PK. Circulating endotoxemia: a novel factor in systemic inflammation and cardiovascular disease in chronic kidney disease. Clin J Am Soc Nephrol 6: 133-141, 2011. doi:10.2215/CJN.04610510.
94. McLellan AC, Thornalley PJ. Glyoxalase activity in human red blood cells fractioned by age. Mech Ageing Dev 48: 63-71, 1989. doi:10.1016/0047-6374(89)90026-2.
95. Medzhitov R. Origin and physiological roles of inflammation. Nature 454: 428-435, 2008. doi:10.1038/nature07201.
96. Medzhitov R, Horng T. Transcriptional control of the inflammatory response. Nat Rev Immunol 9: 692-703, 2009. doi:10.1038/nri2634.
97. Meuwese CL, Stenvinkel P, Dekker FW, Carrero JJ. Monitoring of inflammation in patients on dialysis: forewarned is forearmed. Nat Rev Nephrol 7: 166-176, 2011. doi:10.1038/nrneph.2011.2.
98. Meyring-Wösten A, Zhang H, Ye X, Fuertinger DH, Chan L, Kappel F, Artemyev M, Ginsberg N, Wang Y, Thijssen S, Kotanko P. Intradialytic hypoxemia and clinical outcomes in patients on hemodialysis. Clin J Am Soc Nephrol 11: 616-625, 2016. doi:10.2215/CJN. 08510815.
99. Missailidis C, Hällqvist J, Qureshi AR, Barany P, Heimbürger O, Lindholm B, Stenvinkel P, Bergman P. Serum trimethylamine-N-oxide is strongly related to renal function and predicts outcome in chronic kidney disease. PLoS One 11: e0141738, 2016. doi:10.1371/journal. pone.0141738.
100. Morcos M, Du X, Pfisterer F, Hutter H, Sayed AA, Thornalley P, Ahmed N, Baynes J, Thorpe S, Kukudov G, Schlotterer A, Bozorgmehr F, El Baki RA, Stern D, Moehrlen F, Ibrahim Y, Oikonomou D, Hamann A, Becker C, Zeier M, Schwenger V, Miftari N, Humpert P, Hammes HP, Buechler M, Bierhaus A, Brownlee M, Nawroth PP. Glyoxalase-1 prevents mitochondrial protein modification and enhances lifespan in Caenorhabditis elegans. Aging Cell 7: 260-269, 2008. doi: 10.1111/j.1474-9726.2008.00371.x.
101. Moreno JA, Izquierdo MC, Sanchez-Niño MD, Suárez-Alvarez B, Lopez-Larrea C, Jakubowski A, Blanco J, Ramirez R, Selgas R, Ruiz-Ortega M, Egido J, Ortiz A, Sanz AB. The inflammatory cytokines TWEAK and TNFα reduce renal klotho expression through NF-κB. J Am Soc Nephrol 22: 1315-1325, 2011. doi:10.1681/ASN. 2010101073.
102. Morigi M, Perico L, Rota C, Longaretti L, Conti S, Rottoli D, Novelli R, Remuzzi G, Benigni A. Sirtuin 3-dependent mitochondrial dynamic improvements protect against acute kidney injury. J Clin Invest 125: 715-726, 2015. doi:10.1172/JCI77632.
103. Muteliefu G, Shimizu H, Enomoto A, Nishijima F, Takahashi M, Niwa T. Indoxyl sulfate promotes vascular smooth muscle cell senescence with upregulation of p53, p21, and prelamin A through oxidative stress. Am J Physiol Cell Physiol 303: C126-C134, 2012. doi:10.1152/ajpcell.00329.2011.
104. Nasi M, De Biasi S, Gibellini L, Bianchini E, Pecorini S, Bacca V, Guaraldi G, Mussini C, Pinti M, Cossarizza A. Ageing and inflammation in patients with HIV infection. Clin Exp Immunol 187: 44-52, 2017. doi:10.1111/cei.12814.
105. Oh HJ, Nam BY, Lee MJ, Kim CH, Koo HM, Doh FM, Han JH, Kim EJ, Han JS, Park JT, Yoo TH, Kang SW, Han DS, Han SH. Decreased circulating klotho levels in patients undergoing dialysis and relationship to oxidative stress and inflammation. Perit Dial Int 35: 43-51, 2015. doi:10.3747/pdi.2013.00150.
106. Ozkok A, Aktas E, Yilmaz A, Telci A, Oflaz H, Deniz G, Yildiz A. Decrease in endothelial progenitor cells associated with inflammation, but not with endothelial dysfunction in chronic hemodialysis patients. Clin Nephrol 79: 21-30, 2013. doi:10.5414/CN107318.
107. Pedruzzi LM, Cardozo LF, Daleprane JB, Stockler-Pinto MB, Mon-teiro EB, Leite M Jr., Vaziri ND, Mafra D. Systemic inflammation and oxidative stress in hemodialysis patients are associated with down-regulation of Nrf2. J Nephrol 28: 495-501, 2015. doi:10.1007/s40620-014-0162-0.
108. Poggioli S, Bakala H, Friguet B. Age-related increase of protein glycation in peripheral blood lymphocytes is restricted to preferential target proteins. Exp Gerontol 37: 1207-1215, 2002. doi:10.1016/S0531-5565(02)00145-6.
109. Raj DS, Carrero JJ, Shah VO, Qureshi AR, Bárány P, Heimbürger O, Lindholm B, Ferguson J, Moseley PL, Stenvinkel P. Soluble CD14 levels, interleukin 6, and mortality among prevalent hemodialysis patients. Am J Kidney Dis 54: 1072-1080, 2009. doi:10.1053/j.ajkd.2009. 06.022.
110. Ramezani A, Massy ZA, Meijers B, Evenepoel P, Vanholder R, Raj DS. Role of the Gut Microbiome in Uremia: A Potential Therapeutic Target. Am J Kidney Dis 67: 483-498, 2016. doi:10.1053/j.ajkd.2015. 09.027.
111. Ramírez R, Carracedo J, Soriano S, Jiménez R, Martín-Malo A, Rodríguez M, Blasco M, Aljama P. Stress-induced premature senescence in mononuclear cells from patients on long-term hemodialysis. Am J Kidney Dis 45: 353-359, 2005. doi:10.1053/j.ajkd.2004.10.022.
112. Rodier F, Campisi J. Four faces of cellular senescence. J Cell Biol 192: 547-556, 2011. doi:10.1083/jcb.201009094.
113. Rosin DL, Okusa MD. Dangers within: DAMP responses to damage and cell death in kidney disease. J Am Soc Nephrol 22: 416-425, 2011. doi:10.1681/ASN.2010040430.
114. Rubio-Ruiz ME, Peredo-Escárcega AE, Cano-Martínez A, Guarner-Lans V. An evolutionary perspective of nutrition and inflammation as mechanisms of cardiovascular disease. Int J Evol Biol 2015: 179791, 2015. doi:10.1155/2015/179791.
115. Rutten EP, Gopal P, Wouters EF, Franssen FM, Hageman GJ, Vanfleteren LE, Spruit MA, Reynaert NL. Various mechanistic pathways representing the aging process are altered in COPD. Chest 149: 53-61, 2016. doi:10.1378/chest.15-0645.
116. Salminen A, Huuskonen J, Ojala J, Kauppinen A, Kaarniranta K, Suuronen T. Activation of innate immunity system during aging: NF-κB signaling is the molecular culprit of inflammaging. Ageing Res Rev 7: 83-105, 2008. doi:10.1016/j.arr.2007.09.002.
117. Salminen A, Kaarniranta K. ER stress and hormetic regulation of the aging process. Ageing Res Rev 9: 211-217, 2010. doi:10.1016/j.arr.2010. 04.003.
118. Salminen A, Kaarniranta K, Kauppinen A. Inflammaging: disturbed interplay between autophagy and inflammasomes. Aging (Albany NY) 4: 166-175, 2012. doi:10.18632/aging.100444.
119. Salminen A, Ojala J, Kaarniranta K, Kauppinen A. Mitochondrial dysfunction and oxidative stress activate inflammasomes: impact on the aging process and age-related diseases. Cell Mol Life Sci 69: 2999-3013, 2012. doi:10.1007/s00018-012-0962-0.
120. Schaefer L. Complexity of danger: the diverse nature of damage-associated molecular patterns. J Biol Chem 289: 35237-35245, 2014. doi:10.1074/jbc.R114.619304.
121. Schaffer K, Taylor CT. The impact of hypoxia on bacterial infection. FEBS J 282: 2260-2266, 2015. doi:10.1111/febs.13270.
122. Schlotterer A, Kukudov G, Bozorgmehr F, Hutter H, Du X, Oikonomou D, Ibrahim Y, Pfisterer F, Rabbani N, Thornalley P, Sayed A, Fleming T, Humpert P, Schwenger V, Zeier M, Hamann A, Stern D, Brownlee M, Bierhaus A, Nawroth P, Morcos M. C. elegans as model for the study of high glucose-mediated life span reduction. Diabetes 58: 2450-2456, 2009. doi:10.2337/db09-0567.
123. Schmitt R, Susnik N, Melk A. Molecular aspects of renal senescence. Curr Opin Organ Transplant 20: 412-416, 2015. doi:10.1097/MOT. 0000000000000214.
124. Semenza GL. Oxygen sensing, homeostasis, and disease. N Engl J Med 365: 537-547, 2011. doi:10.1056/NEJMra1011165.
125. Shi K, Wang F, Jiang H, Liu H, Wei M, Wang Z, Xie L. Gut bacterial translocation may aggravate microinflammation in hemodialysis patients. Dig Dis Sci 59: 2109-2117, 2014. doi:10.1007/s10620-014-3202-7.
126. Shiels PG, Stenvinkelb P, Koomanc JP, McGuinness D. Circulating markers of ageing and allostatic load: A slow train coming. Pract Lab Med 7: 49-54, 2017. doi:10.1016/j.plabm.2016.04.002.
127. Shiels PG, McGlynn LM, MacIntyre A, Johnson PC, Batty GD, Burns H, Cavanagh J, Deans KA, Ford I, McConnachie A, McGinty A, McLean JS, Millar K, Sattar N, Tannahill C, Velupillai YN, Packard CJ. Accelerated telomere attrition is associated with relative household income, diet and inflammation in the pSoBid cohort. PLoS One 6: e22521, 2011. doi:10.1371/journal.pone.0022521.
128. Smith ER, Cai MM, McMahon LP, Pedagogos E, Toussaint ND, Brumby C, Holt SG. Serum fetuin-A concentration and fetuin-A-containing calciprotein particles in patients with chronic inflammatory disease and renal failure. Nephrology (Carlton) 18: 215-221, 2013. doi:10.1111/nep.12021.
129. Smith ER, Ford ML, Tomlinson LA, Bodenham E, McMahon LP, Farese S, Rajkumar C, Holt SG, Pasch A. Serum calcification propensity predicts all-cause mortality in predialysis CKD. J Am Soc Nephrol 25: 339-348, 2014. doi:10.1681/ASN.2013060635.
130. Smith ER, Hanssen E, McMahon LP, Holt SG. Fetuin-A-containing calciprotein particles reduce mineral stress in the macrophage. PLoS One 8: e60904, 2013. doi:10.1371/journal.pone.0060904.
131. Sosa Peña MD, Lopez-Soler R, Melendez JA. Senescence in chronic allograft nephropathy. Am J Physiol Renal Physiol 2016, 2016. doi:10.1152/ajprenal.00195.2016.
132. Stenvinkel P, Alvestrand A. Inflammation in end-stage renal disease: sources, consequences, and therapy. Semin Dial 15: 329-337, 2002. doi:10.1046/j.1525-139X.2002.00083.x.
133. Stenvinkel P, Gillespie IA, Tunks J, Addison J, Kronenberg F, Drueke TB, Marcelli D, Schernthaner G, Eckardt KU, Floege J, Froissart M, Anker SD; ARO Steering Committee. Inflammation modifies the paradoxical association between body mass index and mortality in hemodialysis patients. J Am Soc Nephrol 27: 1479-1486, 2016. doi:10.1681/ASN.2015030252.
134. Stenvinkel P, Haase VH. Inflamed fat and mitochondrial dysfunction in end-stage renal disease links to hypoxia-could curcumin be of benefit? Nephrol Dial Transplant 32: 909-912, 2017. doi:10.1093/ndt/gfx052.
135. Stenvinkel P, Ketteler M, Johnson RJ, Lindholm B, Pecoits-Filho R, Riella M, Heimbürger O, Cederholm T, Girndt M. IL-10, IL-6, and TNF-α: central factors in the altered cytokine network of uremia—the good, the bad, and the ugly. Kidney Int 67: 1216-1233, 2005. doi:10.1111/j.1523-1755.2005.00200.x.
136. Stenvinkel P, Kooman JP, Shiels PG. Nutrients and ageing: what can we learn about ageing interactions from animal biology? Curr Opin Clin Nutr Metab Care 19: 19-25, 2016. doi:10.1097/MCO. 0000000000000234.
137. Stenvinkel P, Larsson TE. Chronic kidney disease: a clinical model of premature aging. Am J Kidney Dis 62: 339-351, 2013. doi:10.1053/j. ajkd.2012.11.051.
138. Stenvinkel P, Luttropp K, McGuinness D, Witasp A, Qureshi AR, Wernerson A, Nordfors L, Schalling M, Ripsweden J, Wennberg L, Söderberg M, Bárány P, Olauson H, Shiels PG. CDKN2A/p16INK4(a) expression is associated with vascular progeria in chronic kidney disease. Aging (Albany NY) 9: 494-507, 2017. doi:10.18632/aging.101173.
139. Stenvinkel P, Wang K, Qureshi AR, Axelsson J, Pecoits-Filho R, Gao P, Barany P, Lindholm B, Jogestrand T, Heimberger O, Holmes C, Schalling M, Nordfors L. Low fetuin-A levels are associated with cardiovascular death: Impact of variations in the gene encoding fetuin. Kidney Int 67: 2383-2392, 2005. doi:10.1111/j.1523-1755. 2005.00345.x.
140. Steyers CM III, Miller FJ Jr.. Endothelial dysfunction in chronic inflammatory diseases. Int J Mol Sci 15: 11,324-11,349, 2014. doi:10. 3390/ijms150711324.
141. Stinghen AE, Massy ZA, Vlassara H, Striker GE, Boullier A. Uremic toxicity of advanced glycation end products in CKD. J Am Soc Nephrol 27: 354-370, 2016. doi:10.1681/ASN.2014101047.
142. Straub RH, Schradin C. Chronic inflammatory systemic diseases: An evolutionary trade-off between acutely beneficial but chronically harmful programs. Evol Med Public Health 2016: 37-51, 2016. doi:10.1093/emph/eow001.
143. Sturmlechner I, Durik M, Sieben CJ, Baker DJ, van Deursen JM. Cellular senescence in renal ageing and disease. Nat Rev Nephrol 13: 77-89, 2017. doi:10.1038/nrneph.2016.183.
144. Sun CY, Chang SC, Wu MS. Suppression of Klotho expression by protein-bound uremic toxins is associated with increased DNA methyl-transferase expression and DNA hypermethylation. Kidney Int 81: 640-650, 2012. doi:10.1038/ki.2011.445.
145. Sun YM, Lin KY, Chen YQ. Diverse functions of miR-125 family in different cell contexts. J Hematol Oncol 6: 6, 2013. doi:10.1186/1756-8722-6-6.
146. Supinski GS, Callahan LA. Free radical-mediated skeletal muscle dysfunction in inflammatory conditions. J Appl Physiol (1985) 102: 2056-2063, 2007. doi:10.1152/japplphysiol.01138.2006.
147. Takata Y, Kitami Y, Yang ZH, Nakamura M, Okura T, Hiwada K. Vascular inflammation is negatively autoregulated by interaction between CCAAT/enhancer-binding protein-delta and peroxisome prolifera-tor-activated receptor-γ. Circ Res 91: 427-433, 2002. doi:10.1161/01. RES.0000031271.20771.4F.
148. Tanaka Y, Joki N, Hase H, Iwasaki M, Ikeda M, Ando R, Shinoda T, Inaguma D, Sakaguchi T, Komatsu Y, Koiwa F, Yamaka T, Shige-matsu T. Effect of erythropoietin-stimulating agent on uremic inflammation. J Inflamm (Lond) 9: 17, 2012. doi:10.1186/1476-9255-9-17.
149. Ter Maaten JM, Damman K, Verhaar MC, Paulus WJ, Duncker DJ, Cheng C, van Heerebeek L, Hillege HL, Lam CS, Navis G, Voors AA. Connecting heart failure with preserved ejection fraction and renal dysfunction: the role of endothelial dysfunction and inflammation. Eur J Heart Fail 18: 588-598, 2016. doi:10.1002/ejhf.497.
150. Thevaranjan N, Puchta A, Schulz C, Naidoo A, Szamosi JC, Ver-schoor CP, Loukov D, Schenck LP, Jury J, Foley KP, Schertzer JD, Larché MJ, Davidson DJ, Verdú EF, Surette MG, Bowdish DM. Age-associated microbial dysbiosis promotes intestinal permeability, systemic inflammation, and macrophage dysfunction. Cell Host Microbe 21: 455-466.e4, 2017. doi:10.1016/j.chom.2017.03.002.
151. Titze J, Dahlmann A, Lerchl K, Kopp C, Rakova N, Schröder A, Luft FC. Spooky sodium balance. Kidney Int 85: 759-767, 2014. doi:10.1038/ki.2013.367.
152. Underwood CF, Hildreth CM, Wyse BF, Boyd R, Goodchild AK, Phillips JK. Uraemia: an unrecognized driver of central neurohumoral dysfunction in chronic kidney disease? Acta Physiol (Oxf) 219: 305-323, 2017. doi:10.1111/apha.12727.
153. van den Ham EC, Kooman JP, Schols AM, Nieman FH, Does JD, Franssen FM, Akkermans MA, Janssen PP, van Hooff JP. Similarities in skeletal muscle strength and exercise capacity between renal transplant and hemodialysis patients. Am J Transplant 5: 1957-1965, 2005. doi:10.1111/j.1600-6143.2005.00944.x.
154. van Onna M, Boonen A. The challenging interplay between rheumatoid arthritis, ageing and comorbidities. BMC Musculoskelet Disord 17: 184, 2016. doi:10.1186/s12891-016-1038-3.
155. Vaziri ND, Pahl MV, Crum A, Norris K. Effect of uremia on structure and function of immune system. J Ren Nutr 22: 149-156, 2012. doi:10.1053/j.jrn.2011.10.020.
156. Vaziri ND, Wong J, Pahl M, Piceno YM, Yuan J, DeSantis TZ, Ni Z, Nguyen TH, Andersen GL. Chronic kidney disease alters intestinal microbial flora. Kidney Int 83: 308-315, 2013. doi:10.1038/ki.2012.345.
157. Vaziri ND, Yuan J, Rahimi A, Ni Z, Said H, Subramanian VS. Disintegration of colonic epithelial tight junction in uremia: a likely cause of CKD-associated inflammation. Nephrol Dial Transplant 27: 2686-2693, 2012. doi:10.1093/ndt/gfr624.
158. Wang AY, Sea MM, Tang N, Lam CW, Chan IH, Lui SF, Sanderson JE, Woo J. Energy intake and expenditure profile in chronic peritoneal dialysis patients complicated with circulatory congestion. Am J Clin Nutr 90: 1179-1184, 2009. doi:10.3945/ajcn.2009.28160.
159. Wang DT, Yang YJ, Huang RH, Zhang ZH, Lin X. Myostatin activates the ubiquitin-proteasome and autophagy-lysosome systems contributing to muscle wasting in chronic kidney disease. Oxid Med Cell Longev 2015: 684965, 2015. doi:10.1155/2015/684965.
160. Wątroba M, Szukiewicz D. The role of sirtuins in aging and age-related diseases. Adv Med Sci 61: 52-62, 2016. doi:10.1016/j.advms.2015.09. 003.
161. White WE, Yaqoob MM, Harwood SM. Aging and uremia: Is there cellular and molecular crossover? World J Nephrol 4: 19-30, 2015. doi:10.5527/wjn.v4.i1.19.
162. Witko-Sarsat V, Friedlander M, Nguyen Khoa T, Capeillère-Blandin C, Nguyen AT, Canteloup S, Dayer JM, Jungers P, Drüeke T, Descamps-Latscha B. Advanced oxidation protein products as novel mediators of inflammation and monocyte activation in chronic renal failure. J Immunol 161: 2524-2532, 1998.
163. Woods HA, Wilson JK. An information hypothesis for the evolution of homeostasis. Trends Ecol Evol 28: 283-289, 2013. doi:10.1016/j.tree. 2012.10.021.
164. Xue M, Rabbani N, Thornalley PJ. Glyoxalase in ageing. Semin Cell Dev Biol 22: 293-301, 2011. doi:10.1016/j.semcdb.2011.02.013.
165. Yamada S, Tatsumoto N, Tokumoto M, Noguchi H, Ooboshi H, Kitazono T, Tsuruya K. Phosphate binders prevent phosphate-induced cellular senescence of vascular smooth muscle cells and vascular calcification in a modified, adenine-based uremic rat model. Calcif Tissue Int 96: 347-358, 2015. doi:10.1007/s00223-014-9929-5.
166. Yamada S, Tokumoto M, Tatsumoto N, Taniguchi M, Noguchi H, Nakano T, Masutani K, Ooboshi H, Tsuruya K, Kitazono T. Phosphate overload directly induces systemic inflammation and malnutrition as well as vascular calcification in uremia. Am J Physiol Renal Physiol 306: F1418-F1428, 2014. doi:10.1152/ajprenal.00633.2013.
167. Yamada S, Tokumoto M, Tsuruya K, Tatsumoto N, Noguchi H, Kitazono T, Ooboshi H. Fetuin-A decrease induced by a low-protein diet enhances vascular calcification in uremic rats with hyperphos-phatemia. Am J Physiol Renal Physiol 309: F744-F754, 2015. doi:10.1152/ajprenal.00017.2015.
168. Yamazaki Y, Baker DJ, Tachibana M, Liu CC, van Deursen JM, Brott TG, Bu G, Kanekiyo T. Vascular cell senescence contributes to blood-brain barrier breakdown. Stroke 47: 1068-1077, 2016. doi:10.1161/STROKEAHA.115.010835.
169. Yates FE. Complexity of a human being: changes with age. Neurobiol Aging 23: 17-19, 2002. doi:10.1016/S0197-4580(01)00261-5.
170. Zawada AM, Rogacev KS, Müller S, Rotter B, Winter P, Fliser D, Heine GH. Massive analysis of cDNA Ends (MACE) and miRNA expression profiling identifies proatherogenic pathways in chronic kidney disease. Epigenetics 9: 161-172, 2014. doi:10.4161/epi.26931.
171. Zeng W, Guo YH, Qi W, Chen JG, Yang LL, Luo ZF, Mu J, Feng B. 4-Phenylbutyric acid suppresses inflammation through regulation of endoplasmic reticulum stress of endothelial cells stimulated by uremic serum. Life Sci 103: 15-24, 2014. doi:10.1016/j.lfs.2014.03.007.
172. Zewinger S, Schumann T, Fliser D, Speer T. Innate immunity in CKD-associated vascular diseases. Nephrol Dial Transplant 31: 1813-1821, 2016. doi:10.1093/ndt/gfv358.
173. Zhang J, Hua G, Zhang X, Tong R, Du X, Li Z. Regulatory T cells/T-helper cell 17 functional imbalance in uraemic patients on maintenance haemodialysis: a pivotal link between microinflammation and adverse cardiovascular events. Nephrology (Carlton) 15: 33-41, 2010. doi:10.1111/j.1440-1797.2009.01172.x.
174. Zhang J, Rane G, Dai X, Shanmugam MK, Arfuso F, Samy RP, Lai MK, Kappei D, Kumar AP, Sethi G. Ageing and the telomere connection: An intimate relationship with inflammation. Ageing Res Rev 25: 55-69, 2016. doi:10.1016/j.arr.2015.11.006.
175. Zhao MM, Xu MJ, Cai Y, Zhao G, Guan Y, Kong W, Tang C, Wang X. Mitochondrial reactive oxygen species promote p65 nuclear translocation mediating high-phosphate-induced vascular calcification in vitro and in vivo. Kidney Int 79: 1071-1079, 2011. doi:10.1038/ki.2011.18.
176. Zhou T, Zhang M, Zhao L, Li A, Qin X. Activation of Nrf2 contributes to the protective effect of Exendin-4 against angiotensin II-induced vascular smooth muscle cell senescence. Am J Physiol Cell Physiol 311: C572-C582, 2016. doi:10.1152/ajpcell.00093.2016.
177. Zhu N, Yuan W, Zhou Y, Liu J, Bao J, Hao J, Miao W. High mobility group box protein-1 correlates with microinflammatory state and nutritional status in continuous ambulatory peritoneal dialysis patients. J Artif Organs 14: 125-132, 2011. doi:10.1007/s10047-011-0561-0.